Sanofi Signs Benitec's closest competitor Voyager for $845M, page-30

I agree J8. They aren't in a hurry as they've got a plan in place and they are acting on that plan. No deal until phase 2 data I recall them stating. I guess Cochlear CEO summed it up this week in commenting on their very lovely profit result - for investors in the R&D game to be patient as it's a long cycle. If Benny is the next Cochlear and that includes waiting for Phase 2 results then i'm prepared and sitting in.

There's no risk we're well placed as holders in this tech, and the Sanofi/Voyager deal just reiterates this. Voyager still need to perform to get their near $1B etc. This deal puts pressure on other big pharma watching the space and increases Benitec's bargaining power, no doubt about that. Data first, big pharma signing second, share price at a 89% gradient immediately after that, with settling at something more like one of those US equivalents.